Key Highlights

  • DocGo shares are down 15.22% in pre-market trading to $0.60, despite closing up 6.40% at $0.71 on Monday.
  • Second-quarter Revenue fell to $73.4 million from $80.4 million a year earlier, though excluding the wind-down of migrant-related programs, revenue increased 19% year-over-year.
  • The company sharply widened its full-year 2026 adjusted EBITDA guidance to a loss of $17 million to $22 million, down from prior guidance of a loss of $5 million to $10 million.
  • DocGo also announced a definitive agreement to acquire virtual care provider Hicuity Health, which generated approximately $65 million in trailing twelve-month revenue, alongside new Debt Financing commitments from Perceptive Advisors.

Why the Penny Stock Is Falling

DocGo (NASDAQ:DCGO) shares are trading sharply lower in pre-market activity after the company's second-quarter results overshadowed a newly announced acquisition. DocGo is a New York City-based, technology-enabled provider of mobile health services and medical transportation, delivering care through a proprietary digital platform offering mobile urgent care, remote patient monitoring, chronic care management, and ambulance transportation services across hospitals, health systems, government agencies, and employers.

Total revenue for the second quarter came in at $73.4 million, down from $80.4 million a year earlier, though the decline was entirely attributable to the wind-down of migrant-related programs, which generated zero revenue this quarter versus $18.8 million a year ago. Excluding that program, total revenue increased 19% year-over-year. Net loss widened to $18.0 million from $13.3 million a year earlier. The company achieved record volumes across several Business lines, including a 58% increase in virtual care and lab orders and a 26% increase in healthcare in the home.

Guidance Cut Overshadows Acquisition News

The larger concern for investors appears to be the company's sharply revised full-year 2026 guidance. DocGo narrowed its revenue guidance to a range of $305 million to $310 million, down slightly from prior guidance of $300 million to $315 million, but far more significantly widened its adjusted EBITDA guidance to a loss of $17 million to $22 million, a substantial deterioration from prior guidance of a loss of $5 million to $10 million. Alongside the Earnings report, DocGo announced a definitive agreement to acquire virtual care provider Hicuity Health, which delivers high-acuity virtual clinical care including Tele-ICU and virtual nursing services, and generated approximately $65 million in trailing twelve-month revenue with $4.5 million in adjusted EBITDA. The acquisition will be funded through the assumption of Hicuity's existing debt held by Perceptive Advisors, which has also committed up to $50 million in additional financing to DocGo. Despite the strategic rationale behind the deal, investors appear to be focused more heavily on the deteriorating profitability outlook.

Conclusion

DocGo shares are sharply lower in pre-market trading as a significantly worsened full-year profitability outlook outweighs the company's newly announced acquisition of Hicuity Health. With management still guiding toward a profitable run rate exiting the year, investors will likely be watching closely for evidence that cost-cutting initiatives and the Hicuity integration can help stabilize the company's financial trajectory.